Rebecca Thurston, PhD, explains clinical research and strategies for undermining the power of vasomotor symptoms and insomnia to interrupt sleep.
Sleep disturbances are a well known issue that many women face during menopause, with as many as 26% of midlife women experiencing sleep symptoms that meet the criteria for insomnia.
In a recent interview from the North American Menopause Society’s 2021 Annual Meeting, Rebecca Thurston, PhD, discussed some strategies, including cognitive behavioral therapy, that have been proven to help patients get a better night’s sleep.
In the interview, she notes that sleep issues have been associated with a number of mental health issues including depression, anxiety, health problems and cardiovascular disease.
And in a study presented at the conference, sexual function could also be negatively effected by poor sleep quality.
To learn more, watch the full video below.
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person
December 3rd 2021In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.
Listen
Study links premature menopause to musculoskeletal pain and sarcopenia risks
May 1st 2024A recent study revealed an association between premature menopause and increased risks of musculoskeletal pain and sarcopenia, emphasizing the potential benefits of hormone therapy in mitigating long-term effects.
Read More